Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study

Md. Ismail Hosen(University of Dhaka), Florence Le Calvez‐Kelm(Centre international de recherche sur le cancer), Farin Kamangar, Christian C. Abnet(National Cancer Institute), Mahdi Sheikh(Centre international de recherche sur le cancer), Paolo Boffetta(Centre International de Recherche sur le Cancer), Maria I. Zvereva(Lomonosov Moscow State University), Masoud Sotoudeh(Tehran University of Medical Sciences), Arash Etemadi, Masoud Khoshnia(Shariati Hospital), Catherine Voegele(Centre international de recherche sur le cancer), Ghislaine Scélo(Centre international de recherche sur le cancer), Priscilia Chopard(Centre international de recherche sur le cancer), Gholamreza Roshandel(Golestan University), Nathalie Forey(Centre international de recherche sur le cancer), Hossein Poustchi(Shariati Hospital), Tiffany M. Delhomme(Centre international de recherche sur le cancer), Arash Nikmanesh(Tehran University of Medical Sciences), Sanford M. Dawsey(National Institutes of Health), Patrice Hodonou Avogbe(Centre international de recherche sur le cancer), Geoffroy Durand(Centre international de recherche sur le cancer), Elisabete Weiderpass(St. Elizabeth's Hospital), Matthieu Foll(Centre international de recherche sur le cancer), James McKay(Centre international de recherche sur le cancer), Reza Malekzadeh(Tehran University of Medical Sciences), Arnaud Manel(Infirmerie Protestante), Paul Brennan(Centre International de Recherche sur le Cancer), Paul D Pharaoh(University of Cambridge), E. Vian(Infirmerie Protestante)
EBioMedicine
February 17, 2020
Cited by 84


Related Papers